Eccogene Raises CNY 180 Million in Series B Equity Financing, Propelling its Pipeline of Treatments for Metabolic Diseases ...Middle East

– Proceeds to support the development of Eccogene's clinical-stage metabolic pipeline including ECC5004, a small molecule GLP-1 receptor agonist for obesity and type 2 diabetes, and ECC4703, a THRβ full agonist for NASH and lipid disorders BOSTON and SHANGHAI, June 11, 2023 /PRNewswire/...

Hence then, the article about eccogene raises cny 180 million in series b equity financing propelling its pipeline of treatments for metabolic diseases was published today ( Monday 12/06/2023 - 03:08 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Eccogene Raises CNY 180 Million in Series B Equity Financing, Propelling its Pipeline of Treatments for Metabolic Diseases )

Also on site :

• Cut Assassin’s Creed Black Flag Resynced epilogue scene, that could hint at fresh 18th century stabby hijinks, allegedly taken down by Ubisoft following datamine
• Wingstop Just Put Sour Patch Kids Candy on Its Wings—and the New Flavor Is Coming Just in Time for Halloween
• Ukrainian press gang abducts naked man (VIDEO)